Literature DB >> 31838902

Potassium-Enriched Salt Substitutes as a Means to Lower Blood Pressure: Benefits and Risks.

Raquel C Greer1,2, Matti Marklund3, Cheryl A M Anderson1,4, Laura K Cobb5, Arlene T Dalcin2, Megan Henry1, Lawrence J Appel1,2.   

Abstract

Use of salt substitutes containing potassium chloride is a potential strategy to reduce sodium intake, increase potassium intake, and thereby lower blood pressure and prevent the adverse consequences of high blood pressure. In this review, we describe the rationale for using potassium-enriched salt substitutes, summarize current evidence on the benefits and risks of potassium-enriched salt substitutes and discuss the implications of using potassium-enriched salt substitutes as a strategy to lower blood pressure. A benefit of salt substitutes that contain potassium chloride is the expected reduction in dietary sodium intake at the population level because of reformulation of manufactured foods or replacement of sodium chloride added to food during home cooking or at the dining table. There is empirical evidence that replacement of sodium chloride with potassium-enriched salt substitutes lowers systolic and diastolic blood pressure (average net Δ [95% CI] in mm Hg: -5.58 [-7.08 to -4.09] and -2.88 [-3.93 to -1.83], respectively). The risks of potassium-enriched salt substitutes include a possible increased risk of hyperkalemia and its principal adverse consequences: arrhythmias and sudden cardiac death, especially in people with conditions that impair potassium excretion such as chronic kidney disease. There is insufficient evidence regarding the effects of potassium-enriched salt substitutes on the occurrence of hyperkalemia. There is a need for additional empirical research on the effect of increasing dietary potassium and potassium-enriched salt substitutes on serum potassium levels and the risk of hyperkalemia, as well as for robust estimation of the population-wide impact of replacing sodium chloride with potassium-enriched salt substitutes.

Entities:  

Year:  2019        PMID: 31838902     DOI: 10.1161/HYPERTENSIONAHA.119.13241

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

Review 1.  Electrolytes and Cardiovascular Disease Risk.

Authors:  Jonathan Bennett; Alysha L Deslippe; Christine Crosby; Sally Belles; Jinan Banna
Journal:  Am J Lifestyle Med       Date:  2020-05-08

Review 2.  New wrinkles in hypertension management 2022.

Authors:  Robert M Carey; Paul K Whelton
Journal:  Curr Opin Cardiol       Date:  2022-07-01       Impact factor: 2.108

Review 3.  Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.

Authors:  Amanda Brand; Marianne E Visser; Anel Schoonees; Celeste E Naude
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

4.  Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD.

Authors:  Martin Gritter; Rosa D Wouda; Stanley M H Yeung; Michiel L A Wieërs; Frank Geurts; Maria A J de Ridder; Christian R B Ramakers; Liffert Vogt; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2022-05-24       Impact factor: 14.978

5.  Potassium-Enriched Salt to Lower Stroke Risk: A #NephJC Editorial on the SSaSS Study.

Authors:  Yoshinosuke Shimamura; Michael Turk; Md Abdul Qader; Shweta Shah; Joel M Topf; Swapnil Hiremath
Journal:  Kidney Med       Date:  2022-05-25

Review 6.  Updates in hypertension: new trials, targets and ways of measuring blood pressure.

Authors:  Liann Abu Salman; Jordana B Cohen
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-04       Impact factor: 3.416

Review 7.  No evidence of racial disparities in blood pressure salt sensitivity when potassium intake exceeds levels recommended in the US dietary guidelines.

Authors:  Theodore W Kurtz; Stephen E DiCarlo; Michal Pravenec; R Curtis Morris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-02       Impact factor: 4.733

8.  Potassium chloride-based replacers: modeling effects on sodium and potassium intakes of the US population with cross-sectional data from NHANES 2015-2016 and 2009-2010.

Authors:  Mary M Murphy; Carolyn G Scrafford; Leila M Barraj; Xiaoyu Bi; Kelly A Higgins; Lee-Ann Jaykus; Nga L Tran
Journal:  Am J Clin Nutr       Date:  2021-07-01       Impact factor: 7.045

Review 9.  The impact of baseline potassium intake on the dose-response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials.

Authors:  Liping Huang; Bruce Neal; Jason H Y Wu; Yuli Huang; Matti Marklund; Norm R C Campbell; Feng J He; Sohei Yoshimura; John Chalmers; Kathy Trieu
Journal:  J Hum Hypertens       Date:  2021-03-05       Impact factor: 3.012

10.  Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial.

Authors:  Sudhir Raj Thout; Jie Yu; Maoyi Tian; Mark D Huffman; Clare Arnott; Qiang Li; Praveen Devarsetty; Claire Johnson; Simone Pettigrew; Bruce Neal; Jason H Y Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.